MECHANISMS OF ACTIONS OF ALCOHOL AND OMEGA 3-FATTY ACIDS
MECHANISMS OF ACTIONS OF ALCOHOL AND OMEGA 3-FATTY ACIDS
批准号:
6463551
负责人:
RAJ M LAKSHMAN
金额:
$5.8万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2002-03-31
关键词:
alcoholism /alcohol abuse apolipoprotein E blood lipoprotein metabolism cholesterol ethanol fatty liver genetic regulatory element glycosylation high density lipoproteins human tissue immunochemistry laboratory rat lipid metabolism lipid transport liver metabolism messenger RNA omega 3 fatty acid phospholipids protein structure function protein transport sialyltransferases sphingomyelins tissue /cell culture toxicology transcription factor
中文摘要
描述(改编自申请人的摘要):主要假设
这一竞争的继续应用是:乙醇暴露下调了
α-2,6-唾液酸基转移酶(2,6-ST)在分子水平上导致
载脂蛋白E糖基化缺陷及其与糖尿病的关系
高密度脂蛋白。乙醇还影响神经鞘蛋白(SPM)和其他磷脂(PL)。
高密度脂蛋白。这些缺陷导致胆固醇反向转运(RCT)受损
被低膳食欧米伽3-脂肪酸(Omega 3FA)逆转。这个实验室有
以下出版(10期和1期)和初步数据
上述假说的支持:1.乙醇损害了两者的唾液酸化
通过下调2,6-ST及其信使核糖核酸转移Tf和ApoE。2.两者都有
2,6-ST-mRNA和GAPDHmRNA在两个尸检肝脏中的表达似乎是完整的
来自非酒精对照组的样本。3.50和100 mM乙醇降低ST段
稳定表达Cyp2E(Cyp2E细胞)和高表达Cyp2E的人HepG2细胞中的mRNA
酒精脱氢酶(ADH细胞),但不是野生型。4.然而,
乙醛(Ach)浓度为50µM时,2,6-ST mRNA表达下降,即使在王尔德
打字。5.乙醇破坏肝脏2,6-STmRNA的稳定,可能是通过顺式和反式-
作用因素。6.去唾液酸化的载脂蛋白E与高密度脂蛋白亲和力低,导致其
人和大鼠的RCT功能受损。7.两种慢性疾病的高密度脂蛋白
酒精喂养的大鼠和人类酗酒者表现出RCT缺陷。8.非常低的饮食
Omega 3FA可恢复乙醇对高密度脂蛋白RCT的抑制作用。9.两者都有
20:5和22:6 omega 3FA组高密度脂蛋白含量增加4-4.7倍
组与对照组比较。10.高密度脂蛋白中鞘磷脂(Spm)含量
乙醇组降低,并伴有RCT抑制。11.HDL来自
与不喝酒的人相比,慢性人类酗酒者的高密度脂蛋白SPM也较低。12.
缺乏SPM的高密度脂蛋白显示RCT功能受损。因此,以下是
提出了具体的目标,以检验假设,以了解机制
酒精和omega 3FA的作用:糖基化:特异性目标1:是蛋白质
乙醇诱导的肝脏2,6-ST mRNA失稳的相关因素?
乙醇如何影响2,6-ST蛋白及其mRNA的分布?做
人类酗酒者的肝脏也表现出2,6-ST蛋白及其mRNA?
特定目标2:体内乙醇的影响能否在人体肝脏中模拟
细胞系统?乙醇的活跃代谢是其作用的先决条件吗?
这些细胞系统?什么是顺式和反式因素?
破坏2,6-ST信使核糖核酸?Ach在临床上对这些影响负责吗?
相关级别?功能后果:具体目标3:omega 3 FA如何
改变酒精介导的高密度脂蛋白RCT功能缺陷?具体目标4:做到
乙醇对高密度脂蛋白、SPM和其他脂蛋白的影响?人类酗酒者改变了SPM吗?
以及他们的高密度脂蛋白中的其他PL水平?酒精引起的SPM和其他物质的丢失
是不是?人类酗酒者是否改变了他们的高密度脂蛋白中的SPM和其他PL水平?会吗?
酒精引起的高密度脂蛋白中SPM和其他PL的丢失会影响其RCT功能吗?这个
实验室将在人类和动物系统中使用分子
生物学、免疫化学和生化方法。
英文摘要
DESCRIPTION (Adapted from the applicant's abstract): The major hypotheses of
this competing continuation application are: Ethanol exposure down-regulates
alpha-2,6-sialyltransferase (2,6-ST) at the molecular level leading to
defective glycosylation of apolipoprotein E (ApoE) and its association with
HDL. Ethanol also affects sphingomyelin (SPM) and other phospholipids (PL) of
HDL. These defects lead to impaired reverse cholesterol transport (RCT) that
are reversed by low dietary omega 3-faty acids (omega 3FA). This laboratory has
the following published (10 publication & 1 review) and preliminary data in
support of the above hypotheses: 1. Ethanol impaired sialylation of both
transferring (Tf) and ApoE by down-regulating 2,6-ST and its mRNA. 2. Both
2,6-ST-mRNA and GAPDH mRNA levels seemed to be intact in two autopsy liver
samples from non-alcoholic controls. 3. Ethanol at 50 and 100mM decreased ST
mRNA in human HepG2 cells stably expressing Cyp2E (Cyp2E cells) and high
alcohol dehydrogenase (ADH cells), but not in Wild type. 4. However,
acetaldehyde (Ach) at 50muM concentration decreased 2,6-ST mRNA even in Wilde
type. 5. Ethanol destabilized liver 2,6-STmRNA, presumably via cis and trans-
acting factors. 6. Desialylated ApoE had low affinity for HDL resulting in its
impaired RCT function in both human and rat. 7. HDLs from both chronic
ethanol-fed rats and human alcoholics showed defective RCT. 8. Very low dietary
omega 3FA restored ethanol-mediated inhibition of RCT capacity of HDL. 9. Both
20:5 and 22:6 omega 3FA contents of HDL increased 4-4.7-fold in omega 3FA-fed
group compared to the control group. 10. Sphingomyelin (SPM) content of HDL was
decreased in ethanol group with concomitant inhibition of RCT. 11. HDLs from
chronic human alcoholics also had lower HDL SPM compared to non-drinkers. 12.
HDL devoid of SPM showed impaired RCT function. Therefore, the following
specific aims are proposed to test hypotheses to understand the mechanisms of
actions of alcohol and omega 3FA: Glycosylation: Specific Aim 1: Are protein
factors involved in the ethanol-mediated destabilization of liver 2,6-ST mRNA?
How does ethanol affect the distribution of 2,6-ST protein & its mRNA? Do
livers from human alcoholics also exhibit decreased 2,6-ST protein & its mRNA?
Specific Aim 2: Can the effects of ethanol in vivo be mimicked in human liver
cell systems? Is active metabolism of ethanol a prerequisite for its effects in
these cell systems? What are the cis and trans factors responsible for
destabilizing 2,6-ST mRNA? Is Ach responsible for these effects at clinically
relevant levels? Functional Consequences: Specific Aim 3: How do omega 3 FA
alter ethanol-mediated defects in the RCT function of HDL? Specific Aim 4: Does
ethanol affect the HDL SPM and other PL? Do human alcoholics have altered SPM
and other PL levels in their HDL? Does ethanol-induced loss of SPM and other
PL? Do human alcoholics have altered SPM and other PL levels in their HDL? Does
ethanol-induced loss of SPM and other PL from HDL affect its RCT function? The
laboratory will accomplish these in human and animal systems using molecular
biology, immunochemical and biochemical approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANTI INFLAMMATORY AND ANTIFIBROTIC ACTIONS OF THYMOSIN BETA 4 IN ALD
-
批准号:8854003
-
项目类别:
-
资助金额:$17.57万
-
财政年份:2014
-
负责人:RAJ M LAKSHMAN
-
依托单位:
ANTI INFLAMMATORY AND ANTIFIBROTIC ACTIONS OF THYMOSIN BETA 4 IN ALD
-
批准号:8609964
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2014
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Novel Modulators of Alcohol Induced Metabolic and Liver Injury
-
批准号:8724156
-
项目类别:
-
资助金额:$10.6万
-
财政年份:2013
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8307287
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8504896
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8702054
-
项目类别:
-
资助金额:$39.31万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8460995
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8203160
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8900880
-
项目类别:
-
资助金额:$45.4万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
BRAIN SOCS3 AND PTP1B-ADIPOSE LEPTIN FEEDBACK AXIS IN ALCOHOLIC HEPATOSTEATOSIS
-
批准号:8144479
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2010
-
负责人:RAJ M LAKSHMAN
-
依托单位:
BRAIN SOCS3 AND PTP1B-ADIPOSE LEPTIN FEEDBACK AXIS IN ALCOHOLIC HEPATOSTEATOSIS
-
批准号:8065693
-
项目类别:
-
资助金额:$18.9万
-
财政年份:2010
-
负责人:RAJ M LAKSHMAN
-
依托单位:
MODULATORS OF ALCOHOLIC LIPIDEMIA & STEATOSIS:KEY ROLE OF SCAVENGER RECEPTOR B I
-
批准号:7926902
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2009
-
负责人:RAJ M LAKSHMAN
-
依托单位:
ACTION OF ALCOHOL/QUERCETIN ON ANTI-ATHEROGENIC FACTOR
-
批准号:7146990
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2006
-
负责人:RAJ M LAKSHMAN
-
依托单位:
ACTION OF ALCOHOL & QUERCETIN ON ANTI-ATHEROGENIC FACTORS & ATHEROGENESIS
-
批准号:7267983
-
项目类别:
-
资助金额:$17.59万
-
财政年份:2006
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6542331
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6917377
-
项目类别:
-
资助金额:$6.28万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6744843
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6890039
-
项目类别:
-
资助金额:$34.82万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:7623633
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:7057373
-
项目类别:
-
资助金额:$34.35万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
海外基金